This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Aneurysm and dissection of carotid artery경동맥의 동맥류 및 박리 (경동맥 동맥류 및 박리)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: I72.0 (aneurysm and dissection of carotid artery) | Special Copayment Reduction: V191 (special copayment reduction for cerebrovascular disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsCervical carotid artery dissection, carotid artery aneurysm, cervical carotid dissection, spontaneous carotid artery dissection, internal carotid artery dissection
C. Key featuresAn important cause, accounting for about 15–25% of ischemic strokes in young and middle-aged adults under 45. Occurs spontaneously or after minor trauma, with fibromuscular dysplasia and connective tissue abnormalities acting as predisposing factors.
1. HistoryMajor milestones include the first case report of carotid artery dissection in 1959, the establishment of noninvasive diagnosis by MRI/MRA in 1988, and the 2015 CADISS randomized clinical trial demonstrating the equivalence of antiplatelet and anticoagulant treatment.
2. CausesBroadly divided into spontaneous (intrinsic vessel wall fragility) and traumatic (cervical spine manipulation, traffic accidents, sports injuries); fibromuscular dysplasia, Marfan syndrome, vascular Ehlers-Danlos syndrome and others are underlying predispositions.
3. GeneticsAssociated genes include COL3A1 (vascular EDS), FBN1 (Marfan syndrome), TGFBR1/TGFBR2 (Loeys-Dietz syndrome), PHACTR1 (susceptibility to fibromuscular dysplasia) and COL5A1.
4. General epidemiologyAnnual incidence about 2.6 per 100,000 population (carotid artery dissection); most common in people in their 30s–50s. Carotid artery aneurysm is much rarer and arises mainly as a sequela.
5. PathophysiologyIntimal tear or vasa vasorum rupture → intramural hematoma → luminal stenosis/occlusion or pseudoaneurysm formation → cerebral ischemia via thromboembolism or hypoperfusion.
6. SymptomsHeadache (65%), neck pain (50%), partial Horner syndrome (25%), pulsatile tinnitus, cerebral ischemia (TIA, cerebral infarction) symptoms; stroke symptoms appear hours to days after prodromal headache and neck pain.
7. SignsPartial Horner syndrome (ptosis + miosis), cranial nerve palsy (especially XII), focal neurological deficits such as hemiplegia and aphasia; auscultation of a bruit; neck mass (aneurysm).
8. ScreeningIn unexplained stroke/TIA in young and middle-aged adults, carotid ultrasound or CTA first; regular carotid imaging follow-up in high-risk groups with connective tissue disease.
9. DiagnosisCrescent-shaped intramural hematoma on fat-suppressed T1 MRI (crescent sign), tapered stenosis and flame sign on CTA/MRA, DSA (diagnostic reference standard). High-resolution vessel wall MRI is emerging as the standard.
10. TreatmentAntithrombotic treatment (antiplatelet or anticoagulant; the two arms were equivalent in the CADISS randomized trial) for 3–6 months; carotid angioplasty and stenting if symptoms persist; surgery limited to exceptional cases.
11. PrognosisMost vessels recanalize within 3–6 months; low risk of recurrent stroke (2–3% within 1 year); risk of contralateral dissection higher than in the general population; for aneurysm sequelae, low annual risk of rupture.
12. PreventionEarly diagnosis and follow-up of connective tissue disease and FMD, caution with cervical spine manipulation (therapeutic chiropractic), adherence to antithrombotic treatment, blood pressure control and smoking cessation are the key prevention strategies.
13. ReferencesDebette S & Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009 … and 9 other papers

1. History

The history of medical descriptions of carotid artery dissection begins in 1959, when Javid et al. first reported a case of spontaneous dissection of the cervical internal carotid artery. At that time, diagnosis of dissection relied on invasive angiography, and treatment was mainly surgical. In the 1970s–80s, with the spread of angiography, it began to be recognized that dissection-related stroke occurs not infrequently in young and middle-aged adults. Reports increased especially among athletes, patients who had received chiropractic procedures and patients after trauma.

The clinical introduction of MRI and MRA (magnetic resonance angiography) in 1988 revolutionized the diagnosis of carotid artery dissection. Fat-suppressed T1-weighted MRI made it possible to identify intramural hematoma noninvasively as a crescent-shaped hyperintense lesion, and as a result carotid artery dissection was diagnosed in many young and middle-aged stroke patients previously classified as having an unknown cause. Advances in CTA (computed tomography angiography) also contributed greatly to higher diagnostic rates. Schievink's large cohort study in 1998 systematically described the natural history of carotid artery dissection, its association with fibromuscular dysplasia (FMD) and the risk of recurrence.

On the treatment side, the UK CADISS (Cervical Artery Dissection in Stroke Study) randomized clinical trial published in 2015 reported no significant difference in efficacy between antiplatelet and anticoagulant treatment. This result questioned the prior practice of favoring anticoagulation and led to the wide use of antiplatelet agents, which carry a lower bleeding risk, as a practical alternative. The 2023 AHA/ASA stroke statement summarized in detail the indications for antithrombotic treatment and endovascular treatment of carotid artery dissection, providing up-to-date evidence-based recommendations.

The history of carotid artery aneurysm is also closely linked to carotid artery dissection. Pseudoaneurysm arising as a sequela of dissection is the most common form clinically, while true aneurysm rarely develops due to atherosclerosis, fibromuscular dysplasia, infection (Lemierre syndrome, tuberculosis), trauma and other causes. With advances in endovascular techniques, stent-assisted coil embolization, covered stents and flow diverters have emerged as treatment options replacing surgery.


2. Causes

The causes of carotid artery dissection are broadly divided into spontaneous and traumatic. Spontaneous dissection is based on intrinsic vessel wall fragility, and fibromuscular dysplasia (FMD) is the most commonly accompanying underlying vascular lesion, found in 15–20% of patients with spontaneous carotid artery dissection. FMD is a non-atherosclerotic, noninflammatory vascular disease in which fibrous proliferation of the media and adventitia irregularly weakens the carotid wall, and it is especially common in women of childbearing age. The risk of carotid artery dissection is also markedly increased in the connective tissue disorders vascular Ehlers-Danlos syndrome (vEDS; COL3A1 gene variants), Marfan syndrome (FBN1) and Loeys-Dietz syndrome (TGFBR1/TGFBR2).

Traumatic dissection occurs even after minor trauma, such as cervical hyperextension or hyperflexion injury, chiropractic cervical manipulation, traffic accidents (neck stretching by a seat belt) and sports injuries (abrupt neck movements in wrestling, ballet or yoga). Vertebral artery dissection related to chiropractic cervical manipulation is more common, but carotid artery dissection has also been reported. When minor trauma triggers dissection, underlying vessel wall fragility is presumed to be present in most cases. Among infectious factors, a recent upper respiratory infection (pharyngitis, tonsillitis) can trigger spontaneous dissection, and the inflammatory response associated with acute infection may contribute to weakening of the vessel wall.

The causes of true carotid artery aneurysm are diverse. Atherosclerotic aneurysms occur around the internal carotid bulb (carotid bulb) in elderly patients and carry a high risk of thrombus formation and embolism. Infectious (mycotic) aneurysms arise from bacterial endocarditis, Lemierre syndrome (a cervical thrombophlebitis complication of Fusobacterium necrophorum pharyngeal infection), infection after head and neck surgery and other causes. Delayed aneurysms may also develop from arterial wall damage after neck radiation therapy. Post-traumatic pseudoaneurysm is the formation of a pulsatile hematoma with only the vascular adventitia remaining, as a complication of penetrating injury, traffic accidents or neck surgery (carotid endarterectomy, thyroid surgery).

Common factors that raise the risk of stroke from arterial dissection include hypertension, migraine (especially migraine with aura), recent infection, connective tissue abnormalities and family history. Smoking acts as an independent risk factor. The postpartum period is a time of transiently increased risk of spontaneous carotid and vertebral artery dissection, presumably through pregnancy-related hormones and changes in vessel wall elasticity.


3. Genetics

Carotid artery dissection and aneurysm are in most cases not monogenic diseases, but several monogenic connective tissue disorders and vascular disease genes act as strong predispositions. Vascular Ehlers-Danlos syndrome (vascular EDS, vEDS) is an autosomal dominant disease caused by pathogenic variants in the COL3A1 gene (chromosome 2q31.3), in which abnormal type III collagen makes the arterial wall extremely fragile. Arterial rupture or dissection occurs in more than 20% of vEDS patients, commonly involving the carotid, subclavian, celiac and iliac arteries. A study reporting that the risk of carotid artery dissection is markedly higher in patients with COL3A1 variants than in the general population was published in JACC in 2025.

In Marfan syndrome, aortic aneurysm and dissection are common due to abnormal fibrillin-1 from the FBN1 gene (chromosome 15q21.1), but carotid artery dissection is relatively rare. In Loeys-Dietz syndrome, variants in TGFBR1 (chromosome 9) or TGFBR2 (chromosome 3) cause abnormal TGF-β signaling and increase the risk of craniocervical aneurysm and dissection. The prevalence of arterial events in patients with TGFBR2 variants is reported to be 7.7%.

Fibromuscular dysplasia (FMD) is mostly non-familial, but a single nucleotide polymorphism (SNP rs9349379) in the PHACTR1 gene (chromosome 6p24.1) has been identified as the major susceptibility locus for FMD (OR 1.7). PHACTR1 encodes a protein involved in regulating the actin cytoskeleton of vascular smooth muscle cells and functions as a shared genetic risk factor not only for FMD but also for spontaneous carotid artery dissection, coronary artery dissection (SCAD) and intracranial aneurysm. Rare variants in the COL5A1 (chromosome 17q22) gene are also found in phenotypes associated with FMD and arterial dissection/aneurysm.

Familial cervical artery dissection is reported in about 2–5% of patients with spontaneous carotid artery dissection, and even when no monogenic abnormality is identified, ultrastructural connective tissue abnormalities are sometimes observed on skin biopsy. Genome-wide association studies (GWAS) have shown associations with carotid artery dissection for TSPAN2, COL4A1/COL4A2 and others in addition to PHACTR1, suggesting a polygenic genetic architecture.


4. General epidemiology

The annual incidence of carotid artery dissection (cervical internal carotid artery dissection) is estimated at about 2.6 per 100,000 population, with an age-standardized incidence higher than that of vertebral artery dissection (1.1/100,000). According to studies from major stroke centers in Western countries, about 15–25% of ischemic strokes at age 45 or younger are caused by carotid or vertebral artery dissection. In East Asia, including Korea, a similar proportion of carotid artery dissection among stroke in young and middle-aged adults has been reported, but large-scale domestic epidemiological data are still limited. Age at onset is concentrated in the 30s–50s, with a median age at onset of about 44 years.

Regarding sex distribution, findings differ between studies, but carotid artery dissection is reported to be slightly more common in men or to show no sex difference. In contrast, the association between FMD and spontaneous dissection is observed more strongly in women. Regarding seasonal variation, there are reports that spontaneous carotid artery dissection increases in winter and spring, raising a possible link with the seasonal prevalence of upper respiratory infections. Geographically, it occurs worldwide, including Western countries, Asia and Africa, but many regions lack systematically compiled epidemiological data.

True carotid artery aneurysm is a much rarer disease. Extracranial carotid artery aneurysms account for only about 4–5% of all extracranial aneurysms, and their prevalence is not precisely known. One study found that the prevalence of craniocervical aneurysm in patients with aortic dissection was 0.26%, significantly higher than in the general population without aortic dissection (0.02%). Carotid artery aneurysms are found at a higher rate in patients with accompanying FMD. Pseudoaneurysms occur as sequelae of trauma or dissection, at a high rate especially in groups with repeated neck injury.

The recurrence rate of carotid artery dissection is low, about 2% in the first year and less than 1% per year thereafter. However, the risk of failed recanalization of the ipsilateral vessel or of metachronous dissection of the contralateral carotid or vertebral artery is significantly higher than in the general population, so systematic follow-up after the initial diagnosis is needed. With underlying vascular abnormalities such as FMD, the risk of recurrence and multivessel involvement is higher.


5. Pathophysiology

The pathogenesis of carotid artery dissection begins with a structural abnormality of the arterial wall. There are two main pathways. The first pathway is an intimal tear, in which a small crack in the intima between the vessel lumen and the media lets blood enter the wall and form an intramural hematoma. As the intramural hematoma expands, the lumen narrows eccentrically (stenosis) or becomes completely blocked (occlusion). The second pathway is rupture of the vasa vasorum (the vessels of the vessel) surrounding the adventitial layer, causing hemorrhage within the media that separates the intima-media layer and forms a pseudoaneurysm. A pseudoaneurysm is a saccular structure bounded only by the adventitia or surrounding tissue rather than the full thickness of the arterial wall.

Cerebral ischemia arises from a combination of two mechanisms: thromboembolism and hypoperfusion. Thromboembolism is the pathway in which platelets are activated and aggregate on the exposed subendothelial matrix (collagen, tissue factor), a thrombus forms, and emboli travel to distal cerebral arteries. Clinically, TIA, retinal artery occlusion (Hollenhorst plaques), cortical infarction and the like arise by this mechanism. Hypoperfusion occurs when severe luminal stenosis or occlusion by the intramural hematoma sharply reduces distal cerebral blood flow, causing border-zone infarction (watershed infarction) or lacunar infarction. The two mechanisms often act simultaneously.

During recovery after dissection, the intramural hematoma is absorbed and the vessel recanalizes (about 70–80%), residual stenosis remains, or it progresses to a pseudoaneurysm. A pseudoaneurysm can form thrombus from stagnant flow and become a source of recurrent embolism. The spontaneous resolution rate of pseudoaneurysm after carotid artery dissection is about 30–50%. Horner syndrome results from direct compression or ischemia of sympathetic fibers running along the course of the carotid artery; of its triad of ptosis, miosis and anhidrosis, facial anhidrosis is often absent, giving a partial Horner syndrome pattern.

The hemodynamic mechanisms of carotid artery aneurysm vary with size and structure. In saccular aneurysms, vortex flow develops and thrombus forms, leading to distal embolism or local mass effect (on adjacent cranial nerves or the airway). In fusiform aneurysms, dissection can progress at weakened parts of the wall, or thrombus can fill the whole aneurysm and progress to vessel occlusion.


6. Symptoms

The clinical symptoms of carotid artery dissection are highly variable and broadly divided into local symptoms and ischemic neurological symptoms. Local symptoms are caused by the dissection itself and often precede cerebral ischemic symptoms by hours to days, providing a clue for early diagnosis. Headache is the most common local symptom, occurring in about 65% of all patients; it is often unilateral and throbbing or a persistent dull ache located in the temporal, frontal or periorbital region. Neck pain occurs in about 50%, characteristically along the lateral neck where the dissected vessel runs.

Partial Horner syndrome occurs in about 25% of patients with carotid artery dissection, with miosis and mild ptosis from compression of sympathetic fibers around the carotid artery. Unlike Horner syndrome from other causes, this finding is incomplete because facial anhidrosis is often not present. Pulsatile tinnitus results from turbulent blood flow caused by the dissection and is reported in about 10–20%. Cranial nerve palsy occurs in about 12%, and through direct compression by the hematoma may involve, in order, XII (hypoglossal nerve), IX–XI (jugular foramen nerves) and VI (abducens nerve).

Ischemic neurological symptoms appear as TIA (transient ischemic attack) or cerebral infarction. Internal carotid artery territory symptoms include unilateral motor weakness and sensory disturbance, ipsilateral monocular vision loss (transient monocular blindness from retinal artery occlusion, amaurosis fugax) and aphasia (with dominant hemisphere involvement). Typically, headache and neck pain appear first and neurological deficits follow hours to days later, a pattern characteristic of carotid artery dissection, but neurological symptoms may also occur simultaneously or first. Rarely, symptoms of sympathetic stimulation (sympathetic–parasympathetic imbalance) or postural instability and syncope from hypoperfusion of the ipsilateral hemisphere may occur.

Carotid artery aneurysm may be found incidentally without symptoms, palpated as a pulsatile neck mass, or present with symptoms of compression of adjacent structures (dysphagia, dyspnea, cranial nerve palsy). Embolism from thrombus formation within the aneurysm may also be the first symptom. Because of the extracranial location of carotid artery aneurysms, subarachnoid hemorrhage from rupture is rare, but massive neck bleeding can occur from an external carotid aneurysm, requiring emergency treatment.


7. Signs

Physical examination findings in carotid artery dissection provide important diagnostic clues. Neurological examination reveals findings consistent with internal carotid territory ischemia, such as unilateral motor and sensory abnormalities of the upper and lower limbs, hyperreflexia and pathological reflexes (Babinski reflex), and aphasia. Partial Horner syndrome is the most characteristic sign of carotid artery dissection, and confirming it on slit-lamp or ophthalmologic examination is useful for diagnosis. Anisocoria (smaller pupil on the side of dissection) is observed on penlight pupil examination.

A cervical bruit may be heard on auscultation, but it is not present in all dissection patients and can also be heard in healthy people, so its diagnostic specificity is low. A pulsatile mass on carotid palpation suggests a possible carotid artery aneurysm, which must then be confirmed by imaging. In large carotid artery aneurysms, compression of superficial neck veins may cause visible neck vein distension. Cranial nerve examination may reveal tongue muscle atrophy and deviation (cranial nerve XII palsy), hoarseness (compression of cranial nerve X, the vagus nerve) and weakness of shoulder elevation (compression of cranial nerve XI, the accessory nerve).

Hollenhorst plaques (cholesterol crystals or fibrin-platelet emboli) in the retinal arteries on funduscopic examination strongly suggest embolism from the carotid system. When emboli from carotid artery dissection travel to the retinal arteries, central retinal artery occlusion or branch occlusion may be seen on funduscopy. On general examination, an abdominal bruit from renovascular hypertension suggesting FMD, chest symptoms related to coronary artery dissection and headache related to intracranial aneurysm should also be assessed. When a connective tissue abnormality is suspected, systemic findings of Marfan syndrome or EDS, such as long limbs, a high-arched palate, ectopia lentis and skin hyperextensibility, are also checked.


8. Screening

Because carotid artery dissection is a common cause of ischemic stroke in young and middle-aged adults, it must be included in the differential diagnosis whenever unexplained stroke or TIA occurs before age 45. Carotid Doppler ultrasound is the most accessible test for screening for cervical carotid artery dissection. It can show tapered stenosis, an intraluminal double lumen and a pattern of reduced vascular resistance. However, ultrasound is limited in evaluating intracranial vessels or high cervical lesions (near the skull base), so a negative result cannot completely rule out dissection.

High-risk screening criteria for carotid artery dissection include ① patients aged 45 or younger with ischemic stroke or TIA, ② sudden neurological symptoms accompanied by headache and neck pain, ③ partial Horner syndrome with neurological deficits, ④ neurological symptoms arising after recent (within days) minor neck trauma or chiropractic procedures, and ⑤ people with underlying connective tissue disorders such as FMD, Marfan syndrome and vEDS. Careful evaluation is also needed when there is a family history of the same disease or of carotid artery dissection.

In patients diagnosed with FMD, imaging screening of the carotid and craniocervical vessels as a whole is recommended. FMD is not confined to a single vessel and commonly involves multiple vessels, such as the renal, iliac and vertebral arteries, so systemic vascular evaluation should be considered when FMD is diagnosed. In patients with vascular EDS or Loeys-Dietz syndrome, regular craniocervical vascular imaging follow-up is recommended, and collaboration with a clinical geneticist is important.

Long-term follow-up protocols for patients with a history of carotid artery dissection are not yet standardized, but generally vascular imaging (MRA or CTA) is repeated 3–6 months after onset to confirm vessel healing, residual stenosis and pseudoaneurysm formation. If a pseudoaneurysm is found, further imaging follow-up or endovascular treatment is decided based on its size, thrombus burden and the presence of symptoms.


9. Diagnosis

Imaging criteria for diagnosing carotid artery dissection are divided into noninvasive and invasive tests. MRI + MRA (magnetic resonance angiography) is currently the noninvasive imaging combination used first. A crescent-shaped (crescent sign) hyperintense intramural hematoma on fat-suppressed T1-weighted imaging is the pathognomonic sign of dissection. The intramural hematoma appears isointense or hypointense in the first 48 hours and may be missed, but over the following 2–4 weeks it becomes markedly hyperintense on T1 and persists for about 2 months. MRA shows flame-shaped (flame sign) tapered stenosis or occlusion, or fusiform dilatation due to pseudoaneurysm.

CT angiography (CTA) is practical for evaluating acute carotid artery dissection owing to its fast scanning speed and high spatial resolution. It can show eccentric luminal stenosis, a double lumen (true lumen + false lumen), tapered stenosis and intraluminal thrombus. CTA is less able than MRI to directly depict the intramural hematoma itself, but it is superior for defining the anatomy of aneurysms and pseudoaneurysms. Digital subtraction angiography (DSA) has traditionally been regarded as the diagnostic gold standard for dissection, but because it is invasive and carries risks of radiation exposure and procedure-related complications, it is now performed mainly before endovascular treatment or when noninvasive tests are inconclusive. Characteristic DSA findings of a dissected vessel are the flame sign, double lumen, pseudoaneurysm and intimal flap.

High-resolution vessel wall MRI can directly image not only the vessel lumen but the vessel wall itself, allowing detailed evaluation of the location, size and signal characteristics of the intramural hematoma. It is currently developing into the most promising imaging technique for diagnosing dissection and is also useful for distinguishing dissection from atherosclerosis or vasculitis. Carotid ultrasound is used to screen for dissection in accessible cervical segments and shows an eccentric double lumen, tapered stenosis and increased vessel diameter, but it is limited in evaluating high dissections near the skull base.

As another ancillary test, transcranial Doppler (TCD) can detect reduced distal flow and microembolic signals (HITS), allowing real-time monitoring of embolic risk. Blood tests include C-reactive protein, erythrocyte sedimentation rate and a thrombophilia screening panel (protein C, S, antithrombin III, Factor V Leiden, prothrombin G20210A, antiphospholipid antibodies) to rule out a hypercoagulable state. When a hereditary connective tissue disease is suspected, molecular genetic testing is used to identify variants in genes such as COL3A1, FBN1 and TGFBR1/TGFBR2.


10. Treatment

Treatment of carotid artery dissection is broadly divided into antithrombotic drug therapy, endovascular treatment and surgical treatment. Antithrombotic drug therapy is first-line treatment for most carotid artery dissections. The CADISS (Cervical Artery Dissection in Stroke Study) randomized clinical trial published in 2015 compared 3 months of antiplatelet treatment (mainly aspirin 300 mg/day or aspirin + clopidogrel combination) with anticoagulant treatment (heparin bridge followed by warfarin, target INR 2.0–3.0). The rate of ipsilateral stroke was 2% in the antiplatelet group and 1% in the anticoagulant group, with no significant difference between the two groups (p=0.63). As a bleeding complication, one subarachnoid hemorrhage was reported in the anticoagulant group.

Based on the CADISS results, both antiplatelet agents and anticoagulants are now acceptable options for patients with carotid artery dissection without bleeding risk, and antiplatelet agents (aspirin alone or dual antiplatelet therapy) are preferred in many centers because they are simpler and carry a lower bleeding risk. The 2023 AHA/ASA statement on cervical artery dissection recommends 3–6 months of antithrombotic treatment in ischemic stroke with dissection and states that either antiplatelet agents or anticoagulants may be used. Randomized controlled studies of the newer non–vitamin K oral anticoagulants (NOAC: rivaroxaban, apixaban, dabigatran) are limited, but retrospective studies have reported effects similar to warfarin, and their use is increasing owing to lower bleeding risk and convenient dosing.

Endovascular or surgical treatment is considered in the following cases: ① recurrent TIA or stroke despite adequate antithrombotic treatment, ② a large symptomatic pseudoaneurysm (causing dual thromboembolism or compression symptoms), ③ severe hypoperfusion symptoms due to complete vessel occlusion. Carotid angioplasty and stenting (CAS) recanalizes the stenosis at the dissection site and fixes the intramural hematoma to the vessel wall, with a high technical success rate. Surgical treatment (carotid endarterectomy, vascular reconstruction after aneurysm resection) is performed only when endovascular access is not possible or when defining the tissue structure is essential.

The use of intravenous alteplase (tPA) thrombolysis in carotid artery dissection with acute cerebral infarction was controversial, but recent registry studies have reported that tPA shows safety and efficacy in acute cerebral infarction due to dissection similar to those in cerebral infarction in general. Mechanical thrombectomy can also be performed in large vessel occlusion infarction caused by carotid artery dissection, sometimes combined with stenting when needed. Treatment duration is individualized based on imaging findings of vessel recovery, and vessel recanalization is usually confirmed with follow-up MRA or CTA after 3–6 months.


11. Prognosis

The overall prognosis of carotid artery dissection is relatively good. The recanalization rate of the dissected vessel reaches about 70–80% within 3–6 months, and once complete recanalization occurs, the long-term risk of recurrent stroke is very low. Even when residual stenosis remains (about 10–15%), clinically significant hypoperfusion rarely persists. Progression to pseudoaneurysm occurs in about 20–30%, and many of these resolve spontaneously. A persistent or enlarging pseudoaneurysm can cause complications such as cranial nerve palsy from mechanical compression in addition to embolic risk, so interventional treatment is needed.

The risk of recurrent stroke is highest in the first month and drops sharply thereafter. The risk of recurrent stroke within the first year is about 2–3% under antithrombotic treatment, and the annual recurrence rate thereafter is less than 1%. This is due to the natural healing course after dissection and the thromboembolism-preventing effect of antithrombotic treatment. Long-term functional recovery after carotid artery dissection is determined by the severity of the neurological deficit at the time of dissection. Most patients with only mild deficits or TIA achieve full functional recovery. Even with a severe initial cerebral infarction, cerebral infarction due to carotid artery dissection, unlike cardioembolism, has a low recurrence rate, so the long-term functional prognosis is relatively good.

The risk of metachronous dissection of the contralateral or another vessel is significantly higher than in the general population. The risk of multivessel dissection rises particularly in patients with predispositions such as FMD, connective tissue abnormalities and migraine. Therefore, after a first dissection, lifestyle modification (avoiding violent neck movements, smoking cessation, blood pressure control) together with regular follow-up imaging is recommended. The prognosis of true carotid artery aneurysm varies with size, location, embolic activity and the underlying cause. Small asymptomatic true aneurysms can be observed conservatively, but large ones, those with thrombus or symptomatic ones require endovascular treatment or surgery.


12. Prevention

Primary prevention of carotid artery dissection focuses on early detection and correction of risk factors. Early diagnosis of connective tissue abnormalities is the most important primary prevention strategy. When FMD is diagnosed, imaging evaluation of the craniocervical vessels as a whole is needed, along with blood pressure control and caution with hormonal drugs (including oral contraceptives). When vascular EDS or Loeys-Dietz syndrome is suspected, evaluation by a clinical genetics specialist and genetic counseling for the family are carried out to establish surveillance before arterial complications develop. Genetic testing for COL3A1, FBN1, TGFBR1/TGFBR2 and others enables preventive management in high-risk families.

Caution with cervical manipulation is important for preventing traumatic carotid and vertebral artery dissection. Chiropractic high-velocity cervical manipulation is considered contraindicated in people with risk factors for dissection, and because an association with dissection continues to be reported even in the general population, a careful risk-benefit assessment is needed before the procedure. Care should be taken with abrupt neck movements during sports (wrestling, martial arts, ballet neck movements, etc.). Proper use of seat belts and headrests to prevent traffic injuries, and adherence to safety rules, also help reduce traumatic dissection.

Blood pressure control reduces vessel wall stress and lowers the risk of spontaneous dissection. Because hypertension is an independent risk factor for carotid artery dissection, the target blood pressure (below 140/90 mmHg; below 130/80 mmHg with diabetes or kidney disease) is maintained with lifestyle modification (low-salt diet, regular aerobic exercise, weight management) and, when needed, antihypertensive drugs. Smoking cessation is an important preventive measure that preserves endothelial function of the vessel wall and lowers the risk of thrombus formation. Smoking has been identified as an independent risk factor for carotid artery dissection, so smoking cessation is strongly recommended.

Migraine management is also relevant to preventing carotid artery dissection. Migraine (especially migraine with aura) is known to be a risk factor for carotid artery dissection, and whether this association can be attenuated by appropriate migraine prophylaxis still requires research. In patients with a history of dissection, maintaining the antithrombotic treatment described above for 3–6 months is recommended as a secondary prevention strategy; after recanalization is confirmed, it is common to stop the antithrombotic agent or switch to long-term aspirin monotherapy. Regular follow-up by a neurologist and vascular imaging surveillance are important for early detection and management of residual stenosis, pseudoaneurysm and recurrent dissection.


13. References

  1. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009;8(7):668–678. https://doi.org/10.1016/S1474-4422(09)70084-5 PMID: 19539238
  2. CADISS trial investigators; Markus HS, Hayter E, Levi C, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361–367. https://doi.org/10.1016/S1474-4422(15)70018-9 PMID: 25684164
  3. Markus HS, Levi C, King A, et al. Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. JAMA Neurol. 2019;76(6):657–664. https://doi.org/10.1001/jamaneurol.2019.0072 PMID: 30907929
  4. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001;344(12):898–906. https://doi.org/10.1056/NEJM200103223441206 PMID: 11259724
  5. Debette S, Goeggel Simonetti B, Pfleger L, et al. Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association. Stroke. 2023;54(10):e492–e520. https://doi.org/10.1161/STR.0000000000000457 PMID: 37609826
  6. Bersano A, Morotti A, Pezzini A, et al. Cervical Artery Dissections: Etiopathogenesis and Management. Front Neurol. 2022;13:978514. https://doi.org/10.3389/fneur.2022.978514 PMID: 36110407
  7. Morel A, Naggara O, Touzé E, et al. Mechanism of ischemic infarct in spontaneous cervical artery dissection. Stroke. 2012;43(5):1354–1361. https://doi.org/10.1161/STROKEAHA.111.643338 PMID: 22355008
  8. Giossi A, Volonghi I, Del Zotto E, et al. Pathogenetic Insights from Genetic Analysis of Spontaneous Cervical Artery Dissection. Int J Mol Sci. 2014;15(5):7704–7723. https://doi.org/10.3390/ijms15057704 PMID: 24815069
  9. Kim BJ, Kim SH, Han MK, et al. Cervical artery dissection: frequency and risk factors in Koreans. Eur J Neurol. 2016;23(12):1800–1806. https://doi.org/10.1111/ene.13109 PMID: 27646777
  10. Torina PJ, Glasser AM, Rubin MS, et al. Long-term follow-up of aneurysms developing from the site of carotid artery dissection. AJR Am J Roentgenol. 1999;173(2):459–464. https://doi.org/10.2214/ajr.173.2.10430155 PMID: 10430155